Komori
Fuji (6134) · RiskMitigated

Price Fluctuation Risk of Securities

First written in FY2019. 6 of 18 entries say "Mitigated", first in FY2021-Q1. Latest entry: FY2026.

18entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019MitigatedFY2024-Q1 – FY2024-Q3WorsenedFY2025-H1 – FY20252019: 120192020: 320202021: 220212022: 320222023: 420232024: 220242025: 220252026: 12026
Same theme, other companies
Valuation loss due to declines in the market value of securities heldA theme 257 companies write about · 254 as a headwind · 3 as a tailwind

Fuji moved to the "Worse" side of this theme in 2021, 1 year after the typical company in this theme (2020).

The whole theme swung hardest in 2019: 64 of 143 companies on the "Worse" side.

51 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 259 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「There were no applicable items during the current consolidated fiscal year.」

    With respect to price volatility in securities, no impairment loss was recognized during the fiscal year, while the valuation difference on other securities increased by ¥1,708 million.
  2. FY2026-H1Decrease in investment securities balance due to salesAnnual report

    「This was mainly due to a ¥2,475 million decrease in investment securities resulting from the sale of investment securities.」

    During the interim period, the balance decreased by ¥2,475 million as a result of the sale of investment securities. The valuation difference on other securities decreased by ¥485 million, a reduction from the ¥2,190 million decrease in the interim period of the previous year.
  3. FY2025WorsenedAnnual report

    「In the consolidated fiscal year under review, an impairment loss of ¥304 million was recognized, comprising ¥304 million on securities other than shares and other instruments without market prices classified as other securities.」

    With respect to price volatility risk in securities, an impairment loss of ¥304 million was recognized during the fiscal year, while the valuation difference on other securities also decreased by ¥3,388 million.
  4. FY2025-H1WorsenedAnnual report

    「This was due to a ¥3,059 million decrease in investment securities, mainly as a result of falling share prices.」

    Investment securities decreased by ¥3,059 million as a result of falling share prices, while the valuation difference on other securities also decreased by ¥2,190 million, with the effects of price volatility appearing adversely in the results.
  5. FY2024-Q3MitigatedAnnual report

    「This was due to a ¥4,600 million increase in investment securities, mainly as a result of rising share prices.」

    During the quarter, investment securities increased by ¥4,600 million, mainly as a result of rising share prices, with the effects of price volatility appearing in the results as an increase in valuation.
  6. FY2024-Q2MitigatedAnnual report

    「This was mainly due to a ¥3,606 million increase in construction in progress, resulting from the rebuilding of part of the buildings at the Okazaki Plant, and a ¥4,137 million increase in investment securities, mainly as a result of rising share prices.」

    Investment securities increased by ¥4,137 million as a result of rising share prices, with price volatility risk appearing in the quarter's results as an increase in valuation.
  7. FY2024-Q1MitigatedAnnual report

    「This was due to a ¥2,853 million increase in investment securities, mainly as a result of rising share prices.」

    With respect to price volatility risk in securities, investment securities increased by ¥2,853 million during the quarter as a result of rising share prices.
  8. FY2023WorsenedAnnual report

    「In the consolidated fiscal year under review, an impairment loss of ¥49 million was recognized, comprising ¥49 million on shares and other instruments without market prices classified as other securities.」

    With respect to price volatility and valuation risk in securities, an impairment loss of ¥49 million was recognized, following the ¥32 million loss in the previous fiscal year.
  9. FY2023-Q3MitigatedAnnual report

    「Valuation difference on other securities △ 397」

    The valuation difference on other securities decreased by ¥397 million, narrowing from the ¥1,122 million decrease disclosed for the cumulative period of the previous quarter.
  10. FY2023-Q2WorsenedAnnual report

    「Valuation difference on other securities △ 1,122」

    The valuation difference on other securities decreased by ¥1,122 million during the cumulative second quarter period, indicating deterioration in the valuation of financial assets due to price volatility.
  11. FY2022WorsenedAnnual report

    「In the consolidated fiscal year under review, an impairment loss of ¥32 million was recognized, comprising ¥32 million on securities other than shares and other instruments without market prices classified as other securities.」

    A ¥32 million impairment loss was recognized as a result of price volatility in securities, and a further ¥93 million loss on sale was also recorded.
  12. FY2022-Q3Continued recognition of losses on the sale and valuation of investment securitiesAnnual report

    「Loss on sale of investment securities 47 Valuation loss on investment securities 31」

    During the cumulative third quarter period, a ¥47 million loss on the sale of investment securities and a ¥31 million valuation loss were recognized, with losses resulting from price volatility continuing to be recorded.
  13. FY2022-Q2Rising share prices alongside losses on the sale of investment securitiesAnnual report

    「This was due to a ¥301 million increase in investment securities, mainly as a result of rising share prices.」

    While investment securities increased by ¥301 million as a result of rising share prices, a ¥27 million loss on the sale of investment securities was also recognized during the quarter, with the effects of price volatility occurring in tandem.
  14. FY2021MaterialisedAnnual report

    「In the consolidated fiscal year under review, an impairment loss of ¥38 million was recognized, comprising ¥38 million on shares classified as other securities with market prices.」

    While the valuation of investment securities as a whole increased as a result of rising share prices, price volatility risk on securities was realized as a ¥38 million impairment loss.
  15. FY2021-Q2Rising share prices and valuation losses occurring concurrentlyAnnual report

    「This was due mainly to a ¥4.488 billion increase in investment securities resulting from rising share prices and other factors.」

    Although investment securities increased due to rising share prices, a valuation loss of ¥38 million on investment securities was also recognized during the cumulative period of the current quarter, with the effects of price fluctuations occurring concurrently.
  16. FY2021-Q1MitigatedAnnual report

    「This was due mainly to a ¥2.681 billion increase in investment securities resulting from rising share prices and other factors.」

    Following a decrease in investment securities due to falling share prices in the previous fiscal year, investment securities increased by ¥2.681 billion in the current quarter due to rising share prices.
  17. FY2020MaterialisedAnnual report

    「This was due mainly to a ¥4.645 billion decrease in investment securities resulting from falling share prices and other factors.」

    The price fluctuation risk for securities materialized as a ¥4.645 billion decrease in investment securities and a ¥3.683 billion decrease in valuation differences on other securities.
  18. FY2019First statedAnnual report

    「The Group holds investment securities to establish and strengthen business relationships that contribute to business expansion, development, stabilization, and efficiency. A significant decline in market value could affect the Group's operating results and financial position.」

    Newly disclosed the risk of declining market prices for investment securities as a separate item. During the fiscal year, investment securities decreased by ¥8.542 billion due to falling share prices, and valuation differences on other securities also decreased by ¥2.82 billion.
Moved together

"Expansion of operating loss in Other businesses" moved the same way as this thread, in the same document, in 5 of its 18 moves.

554444★123456
  1. ★This thread
  2. 1Expansion of operating loss in Other businesses5×
  3. 2Risks of Soaring Prices, Shortages and Supply Interruptions for Key Materials5×
  4. 3Innovative Product Development as a World-Leading Robot Manufacturer4×
  5. 4Continuous Supply of High-Value-Added Products and Enhancement of Product Competitiveness4×
  6. 5Shareholder Returns Through Dividends and Share Repurchases4×
  7. 6Economic Uncertainty in Japan and Overseas and Cautious Capital Investment4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Fuji's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.